# HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC

> **NCT00605150** · — · COMPLETED · sponsor: **Wake Forest University Health Sciences** · enrollment: 11 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **RADIATION:** TheraSphere-Yttrium 90 microsphere

## Key facts

- **NCT ID:** NCT00605150
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2022-04-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00605150

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00605150, "HDE Use Protocol of TheraSphere for Treatment of Unresectable HCC". Retrieved via MORVS 2026-10-29 from https://api.morvs.ai/clinical/NCT00605150. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*